Impact of Transcranial Direct Current Stimulation on the Capacity to Perform Burpees

June 18, 2024 updated by: Salvador Romero Arenas, Universidad Católica San Antonio de Murcia

Impact of Transcranial Direct Current Stimulation on the Capacity to Perform Burpees: a Randomized Controlled Trial

Introduction and Background:

Transcranial direct current stimulation (tDCS) has emerged as a potential intervention to improve physical performance. The primary aim of this study is to investigate the effects of tDCS applied to the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) on performance in a maximal effort task, specifically the No Jump Burpee exercise.

Study Design:

This study will utilize a double-blind crossover design, where each subject will complete three experimental conditions: a-DLPFC, a-M1, and SHAM.

Participants:

Twenty healthy male subjects will be recruited for the study.

Intervention:

Each participant will undergo three conditions in a randomized order:

a-DLPFC: tDCS applied to the dorsolateral prefrontal cortex.

a-M1: tDCS applied to the primary motor cortex. SHAM: Placebo stimulation.

Procedure:

Prior to performing the No Jump Burpee exercise to exhaustion, tDCS will be administered at a current of 2 milliampere (mA) for 20 minutes.

Measurements:

The following variables will be measured during the exercise:

Total number of repetitions of the No Jump Burpee exercise. Vastus lateralis muscle oxygen saturation. Heart rate. Subjective perception of exertion (RPE).

Data Analysis:

Repeated measures ANOVAs will be used to analyze the effects of the different tDCS conditions on the performance outcomes.

Ethical Considerations:

The study protocol will be reviewed and approved by an appropriate ethics committee. Written informed consent will be obtained from all participants before participation in the study.

Objectives:

The primary objective is to evaluate the impact of tDCS on physical performance, specifically measuring the total number of repetitions of the No Jump Burpee exercise. Secondary objectives include assessing the changes in muscle oxygen saturation, heart rate, and subjective perception of exertion.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Murcia
      • Guadalupe, Murcia, Spain, 30107
        • Catholic University of Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy subject.
  • No use of any ergogenic substance.
  • Participants must be recreationally active, defined as engaging in moderate physical activity at least 3 times per week for the past 6 months

Exclusion Criteria:

  • Any contraindications to transcranial Direct Current Stimulation, such as metallic implants in the head, active implanted medical devices (e.g., pacemakers), or skin conditions affecting the scalp.
  • Current or recent (within the past 6 months) substance abuse, including alcohol or recreational drugs.
  • Musculoskeletal injury within the past 6 weeks.
  • Lower extremity pain above 3 or more according to numeric pain scale.
  • History of epilepsy or convulsive crisis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: tDCS Targeting the Dorsolateral Prefrontal Cortex (DLPFC)
Participants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the DLPFC. The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of DLPFC stimulation on performance during a maximal effort "No Jump Burpee" exercise.
The anodic electrode will be placed on the left DLPFC (area F3) and the cathode on the right orbitofrontal cortex (area Fp2). Participants will receive 20 minutes of tDCS at 2 mA while seated.
Experimental: tDCS Targeting the Primary Motor Cortex (M1)
Participants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the primary motor cortex (M1). The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of M1 stimulation on performance during a maximal effort "No Jump Burpee" exercise.
The anodes will be placed over C3 and C4 (according to EEG 10-20 system), and the cathodes over the ipsilateral shoulders. Participants will receive 20 minutes of tDCS at 2 mA while seated.
Sham Comparator: SHAM tDCS
Participants in this arm will receive a sham tDCS session, which simulates the experience of tDCS without actual stimulation. This arm serves as a control to ensure the blinding of participants and evaluators.
The electrodes will be placed as in the other conditions, but the stimulation will be switched off after 30 seconds, providing an initial stinging sensation without continuous stimulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of "No Jump Burpees" to Exhaustion
Time Frame: Measured immediately at the end of each experimental session (DLPFC, M1, SHAM), approximately 5-10 minutes after the start of the test..
The primary objective of the study is to measure the number of repetitions of the "No Jump Burpee" exercise that participants can perform until exhaustion. This exercise is performed at a cadence of 20 burpees per minute, and exhaustion is determined when the participant can no longer maintain the correct pace or technique.
Measured immediately at the end of each experimental session (DLPFC, M1, SHAM), approximately 5-10 minutes after the start of the test..

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rating of Perceived Exertion (RPE)
Time Frame: Measured every 20 seconds during exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Assessment of perceived exertion using the Borg CR10 scale, measured every 20 seconds during exercise.
Measured every 20 seconds during exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Muscle Oxygen Saturation in the Vastus Lateralis
Time Frame: Measured continuously at a frequency of 1 Hz during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Continuous measurement of muscle oxygen saturation (SmO2) using a near-infrared spectroscopy (NIRS) device.
Measured continuously at a frequency of 1 Hz during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Heart Rate During Exercise
Time Frame: Measured continuously on a beat-by-beat basis during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.
Continuous measurement of heart rate during the performance of the "No Jump Burpee" exercise until exhaustion.
Measured continuously on a beat-by-beat basis during the exercise, from the start until the participant reaches exhaustion, approximately 5-15 minutes per session.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood State Before Exercise
Time Frame: Before each experimental session.
Assessment of mood state using the Profile of Mood States (POMS) before and after each exercise session. The POMS is a psychological rating scale used to assess transient, distinct mood states. The scale consists of 65 items, each rated on a 5-point scale from 0 (Not at all) to 4 (Extremely). The minimum score is 0, and the maximum score is 260. Higher scores indicate a worse mood state.
Before each experimental session.
Anxiety Level Before Exercise
Time Frame: Before each experimental session
Assessment of anxiety using the Beck Anxiety Inventory (BAI) before each exercise session. The BAI is a 21-item self-report inventory used to measure the severity of an individual's anxiety. Each item is scored on a 4-point scale ranging from 0 (Not at all) to 3 (Severely). The minimum score is 0, and the maximum score is 63. Higher scores indicate higher levels of anxiety.e session.
Before each experimental session
Sleep Quality on the Night Prior to Exercise
Time Frame: Before each experimental session.
Assessment of sleep quality using the Pittsburgh Sleep Quality Index (PSQI) before each exercise session. The PSQI is a self-rated questionnaire that assesses sleep quality and disturbances over a 1-month time interval. It consists of 19 items, generating seven component scores that add up to a global score. The global score ranges from 0 to 21, with higher scores indicating worse sleep quality.
Before each experimental session.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2024

Primary Completion (Actual)

March 8, 2024

Study Completion (Actual)

April 15, 2024

Study Registration Dates

First Submitted

June 13, 2024

First Submitted That Met QC Criteria

June 18, 2024

First Posted (Actual)

June 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 25, 2024

Last Update Submitted That Met QC Criteria

June 18, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CE-031908-A
  • PID2021-128204OA-I00-AEI/FEDER (Other Grant/Funding Number: Spanish Ministry of Science, Innovation, and Universities)
  • ED431B 2021/28 (Other Grant/Funding Number: Xunta de Galicia)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transcranial Direct Current Stimulation

Clinical Trials on tDCS targeting DLPFC

Subscribe